2014

Mount Sinai shows interest in medical marijuana trial

Mount Sinai shows interest in medical marijuana trial

CAPITAL NEW YORK

Mount Sinai Health System is proposing to work with Tilray, a British Columbia medical marijuana company founded in 2013, to operate a clinical trial that would test the effectiveness of certain strains of the drug on severe forms of epilepsy.

Medicinal marijuana grower and UBC hope to test pot as PTSD treatment

Medicinal marijuana grower and UBC hope to test pot as PTSD treatment

THE GLOBE AND MAIL

Tilray announced Thursday it has teamed up with researchers at the University of British Columbia’s Okanagan campus to conduct the first clinical trial in Canada to test the impact of medicinal marijuana on PTSD sufferers.

UBC and Tilray Partner for Canada’s First PTSD Cannabis Study

UBC and Tilray Partner for Canada’s First PTSD Cannabis Study

BUSINESSWIRE

Pending regulatory approvals, the UBC-Tilray study is poised to be one of the first in the world to run a large-scale clinical trial examining medical cannabis as a treatment for a mental health disorder.

B.C. medical marijuana producer hopes to sponsor PTSD study

B.C. medical marijuana producer hopes to sponsor PTSD study

VANCOUVER SUN

A B.C. medical marijuana producer is seeking approval from Health Canada to sponsor the first study in Canada on the safety and effectiveness of cannabis for post-traumatic stress disorder (PTSD) among sexual assault victims, military veterans and first responder personnel.

Investors take aim at Canada’s marijuana industry

Investors take aim at Canada’s marijuana industry

THE GLOBE AND MAIL

Nanaimo-based Tilray has constructed a large, pristine operation on Vancouver Island, backed by Seattle private equity player Privateer Holdings, which has pumped considerable dollars into the U.S. tech sector over the years. The sprawling, brightly-lit facility is a testament to medical marijuana’s sanitized future, where staff wear white polyethylene suits and blue gloves when handling the plants.

How to Grow a Marijuana Portfolio Company

How to Grow a Marijuana Portfolio Company

WALL STREET JOURNAL

Private Equity Beat was on hand as Tilray held a ribbon-cutting ceremony April 28 to commence shipping its products. The company hopes to have the space, which is now 70% finished, completed by Sept. 1 with the expectation that it will serve about 8,000 patients.